Literature DB >> 3083672

Improved growth of three uremic children by nocturnal nasogastric feedings.

C F Strife, M Quinlan, K Mears, M L Davey, C Clardy.   

Abstract

Three children with high-output renal insufficiency (estimated creatinine clearance, 20 to 25 mL/min/1.73 sq m) and linear and ponderal growth retardation were administered nocturnal nasogastric (NG) feedings at home by trained parents. The NG feedings were initiated at 50 kcal/kg/night and increased as needed to establish and maintain weight gain. Nocturnal feedings were continued for 13.5, 16, and 11 months, respectively. Improved caloric intake reestablished the velocity of weight gain from less than 5% to greater than 95% in each patient. Linear growth velocity improved from less than 5% in two patients and 40% in one patient to greater than 95% in two patients and 80% in the third patient. No change was observed in serum creatinine, electrolyte, calcium, or phosphorus levels. The serum urea nitrogen level remained below 100 mg/dl. Ensuring adequate caloric intake by nocturnal NG feedings, in addition to standard therapy, improved both ponderal and linear growth velocity.

Entities:  

Mesh:

Year:  1986        PMID: 3083672     DOI: 10.1001/archpedi.1986.02140190048022

Source DB:  PubMed          Journal:  Am J Dis Child        ISSN: 0002-922X


  10 in total

Review 1.  Tube feeding in children with chronic kidney disease: technical and practical issues.

Authors:  Lesley Rees; Mary L Brandt
Journal:  Pediatr Nephrol       Date:  2009-12-01       Impact factor: 3.714

2.  "A cat burglar": an unusual reason for growth failure despite nocturnal nasogastric feedings in a uremic child.

Authors:  R W Chesney; R Adelman; I Zelikovic; G Rhodes; R Maughan; P Papathakis
Journal:  Pediatr Nephrol       Date:  1988-07       Impact factor: 3.714

Review 3.  Nutritional management and growth in children with chronic kidney disease.

Authors:  Lesley Rees; Helen Jones
Journal:  Pediatr Nephrol       Date:  2012-07-24       Impact factor: 3.714

4.  Growth in very young children undergoing chronic peritoneal dialysis.

Authors:  Lesley Rees; Marta Azocar; Dagmara Borzych; Alan R Watson; Anja Büscher; Alberto Edefonti; Ilmay Bilge; David Askenazi; Giovanna Leozappa; Claudia Gonzales; Koen van Hoeck; Donna Secker; Aleksandra Zurowska; Kai Rönnholm; Antonia H M Bouts; Heather Stewart; Gema Ariceta; Bruno Ranchin; Bradley A Warady; Franz Schaefer
Journal:  J Am Soc Nephrol       Date:  2011-10-21       Impact factor: 10.121

5.  Infectious outcomes following gastrostomy in children receiving peritoneal dialysis.

Authors:  Chanel Prestidge; Jane Ronaldson; William Wong; Maria Stack; Tonya Kara
Journal:  Pediatr Nephrol       Date:  2014-12-04       Impact factor: 3.714

6.  Recombinant human growth hormone treatment in infants with chronic renal failure.

Authors:  H Maxwell; L Rees
Journal:  Arch Dis Child       Date:  1996-01       Impact factor: 3.791

7.  Nasogastric feeding at home: acceptability and safety.

Authors:  C E Holden; J W Puntis; C P Charlton; I W Booth
Journal:  Arch Dis Child       Date:  1991-01       Impact factor: 3.791

8.  Experience with continuous cycling peritoneal dialysis during the first year of life.

Authors:  I B Salusky; T von Lilien; M Anchondo; P A Nelson; R N Fine
Journal:  Pediatr Nephrol       Date:  1987-04       Impact factor: 3.714

Review 9.  Nutrition in children with CRF and on dialysis.

Authors:  Lesley Rees; Vanessa Shaw
Journal:  Pediatr Nephrol       Date:  2007-01-10       Impact factor: 3.714

Review 10.  Delivery of a nutritional prescription by enteral tube feeding in children with chronic kidney disease stages 2-5 and on dialysis-clinical practice recommendations from the Pediatric Renal Nutrition Taskforce.

Authors:  Lesley Rees; Vanessa Shaw; Leila Qizalbash; Caroline Anderson; An Desloovere; Laurence Greenbaum; Dieter Haffner; Christina Nelms; Michiel Oosterveld; Fabio Paglialonga; Nonnie Polderman; José Renken-Terhaerdt; Jetta Tuokkola; Bradley Warady; Johan Van de Walle; Rukshana Shroff
Journal:  Pediatr Nephrol       Date:  2020-07-29       Impact factor: 3.714

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.